New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2013
08:56 EDTLPNTLifePoint Hospitals 2013 D&A higher than expected, says UBS
UBS said LifePoint advised for higher 2013 D&A of $30B-$35B, substantially higher than expected and as much as a 25c earnings headwind in 2013. Shares are Neutral rated with a $39 price target.
News For LPNT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 16, 2014
10:01 EDTLPNTOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:14 EDTLPNTLifePoint Hospitals upgraded at RW Baird
As previously reported, Baird upgraded LifePoint to Outperform from Neutral. The firm upgraded shares based on valuation, M&A pipeline momentum, improved core operations, and potential further ACA benefit. Price target raised to $76 from $70.
06:09 EDTLPNTLifePoint Hospitals upgraded to Outperform from Neutral at RW Baird
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use